{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T10:30:55Z","timestamp":1781346655639,"version":"3.54.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.transci.2019.04.009","type":"journal-article","created":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T11:06:39Z","timestamp":1555671999000},"page":"258-261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Types of fresh plasma with focus on therapeutic plasma exchange"],"prefix":"10.1016","volume":"58","author":[{"given":"Olivier","family":"Garraud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Coppo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2019.04.009_bib0005","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/labmed\/lmx027","article-title":"Plasma transfusion demystified: a review of the key factors influencing the response to plasma transfusion","volume":"48","author":"Bryan","year":"2017","journal-title":"Lab Med"},{"key":"10.1016\/j.transci.2019.04.009_bib0010","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1182\/asheducation-2017.1.632","article-title":"Plasma exchange in thrombotic microangiopathies (TMAs) other than thrombotic thrombocytopenic purpura (TTP)","volume":"1","author":"Winters","year":"2017","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"7-8 Pt 2","key":"10.1016\/j.transci.2019.04.009_bib0015","doi-asserted-by":"crossref","first-page":"e299","DOI":"10.1016\/j.lpm.2016.06.021","article-title":"Focus on fresh frozen plasma - facilitating optimal management of bleeding through collaboration between clinicians and transfusion specialists on component specifications","volume":"45","author":"MacLennan","year":"2016","journal-title":"Presse Med"},{"key":"10.1016\/j.transci.2019.04.009_bib0020","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.tracli.2018.07.007","article-title":"Plasma for direct therapeutic use, for today and tomorrow: a short critical overview","volume":"25","author":"Garraud","year":"2018","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.transci.2019.04.009_bib0025","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.transci.2017.11.023","article-title":"Are all therapeutic plasma preparations the same: Is it worth assessing them in clinical trials?","volume":"56","author":"Garraud","year":"2017","journal-title":"Transfus Apher Sci"},{"issue":"84","key":"10.1016\/j.transci.2019.04.009_bib0030","article-title":"Blood and blood components: from similarities to differences","volume":"5","author":"Garraud","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.transci.2019.04.009_bib0035","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/trf.14415","article-title":"Who\u2019s afraid of incompatible plasma? A balanced approach to the safe transfusion of bloodproducts containing ABO-incompatible plasma","volume":"58","author":"Yazer","year":"2018","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2019.04.009_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/vox.12251","article-title":"Thawed and liquid plasma\u2014what do we know?","volume":"109","author":"Cardigan","year":"2015","journal-title":"Vox Sang"},{"issue":"Suppl 1","key":"10.1016\/j.transci.2019.04.009_bib0045","first-page":"65S","article-title":"The evolving role of lyophilized plasma in remote damage control resuscitation in the French Armed Forces Health Service","volume":"53","author":"Sailliol","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2019.04.009_bib0050","volume":"15","year":"2017"},{"issue":"August (4)","key":"10.1016\/j.transci.2019.04.009_bib0055","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/bjh.12403","article-title":"Update on the use of pathogen-reduced human plasma and platelet concentrates","volume":"162","author":"Seltsam","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2019.04.009_bib0060","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1586\/epr.11.58","article-title":"Proteomics of blood and derived products: what\u2019s next?","volume":"8","author":"Prudent","year":"2011","journal-title":"Expert Rev Proteomics"},{"key":"10.1016\/j.transci.2019.04.009_bib0065","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1537-2995.2012.03766.x","article-title":"Blood donors implicated in transfusion-related acute lung injury with patient- specific HLAantibodies are more broadly sensitized to HLA antigens compared to other blood donors","volume":"53","author":"Saw","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2019.04.009_bib0070","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1111\/j.1537-2995.2009.02556.x","article-title":"National Heart, Lung, and Blood Institute (NHLBI) Retrovirus Epidemiology Donor Study-II. Prevalence of HLA antibodies in remotely transfused or alloexposed volunteer blood donors","volume":"50","author":"Kakaiya","year":"2010","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2019.04.009_bib0075","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.tmrv.2017.07.001","article-title":"Analysis of transfusion-related acute lung injury and possible transfusion-related acute lung injury reported to the French hemovigilance network from 2007 to 2013","volume":"32","author":"Andreu","year":"2018","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.transci.2019.04.009_bib0080","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/vox.12573","article-title":"Transfusion-related acute lung injury risk mitigation: an update","volume":"112","author":"Otrock","year":"2017","journal-title":"Vox Sang"},{"key":"10.1016\/j.transci.2019.04.009_bib0085","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/bja\/aer009","article-title":"Anaphylactic reaction after methylene blue-treated plasma transfusion","volume":"106","author":"Dewachter","year":"2011","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.transci.2019.04.009_bib0090","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1182\/blood-2013-09-524348","article-title":"Hepatitis E transmission by transfusion of Intercept blood system-treated plasma","volume":"123","author":"Hauser","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.transci.2019.04.009_bib0095","doi-asserted-by":"crossref","DOI":"10.1111\/vox.12007","article-title":"A regional haemovigilance retrospective study of four types of therapeutic plasma in a ten-year survey period in France","volume":"104","author":"Bost","year":"2013","journal-title":"Vox Sang"},{"key":"10.1016\/j.transci.2019.04.009_bib0100","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/vox.12300","article-title":"Independent evaluation of tolerance of therapeutic plasma inactivated by amotosalen-HCl- UVA (Intercept \u2122) over a 5-year period of extensive delivery","volume":"109","author":"Bost","year":"2015","journal-title":"Vox Sang"},{"key":"10.1016\/j.transci.2019.04.009_bib0105","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1111\/trf.14245","article-title":"Comparing transfusion reaction rates for various plasma types: a systematic review and meta- analysis\/regression","volume":"57","author":"Saadah","year":"2017","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2019.04.009_bib0110","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/bjh.15167","article-title":"British Society of Haematology Guidelines on the spectrum of fresh frozen plasma and cryoprecipitate products: their handling and use in various patient groups in the absence of major bleeding","volume":"181","author":"Green","year":"2018","journal-title":"Br J Haematol"},{"issue":"June (18)","key":"10.1016\/j.transci.2019.04.009_bib0115","first-page":"30017","article-title":"International collaboration for transfusion medicine guidelines (ICTMG). Quality of evidence-based guidelines for transfusion of red blood cells and plasma: a systematic review","volume":"1","author":"Pavenski","year":"2018","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.transci.2019.04.009_bib0120","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1001\/2013.jamasurg.387","article-title":"PROMMTT Study Group. The prospective, observational, multicenter, major trauma transfusion (PROMMTT) study: comparative effectiveness of a time-varying treatment with competing risks","volume":"148","author":"Holcomb","year":"2013","journal-title":"JAMA Surg"},{"issue":"313","key":"10.1016\/j.transci.2019.04.009_bib0125","first-page":"471","article-title":"PROPPR Study Group. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial","volume":"3","author":"Holcomb","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.transci.2019.04.009_bib0130","first-page":"149","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice-evidence-Based approach from the writing committee of the american society for apheresis: the seventh special issue","volume":"31","author":"Schwartz","year":"2016","journal-title":"J Clin Apher"},{"key":"10.1016\/j.transci.2019.04.009_bib0135","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1182\/blood-2016-10-709857","article-title":"Thrombotic thrombocytopenic purpura","volume":"129","author":"Joly","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.transci.2019.04.009_bib0140","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.tracli.2017.05.015","article-title":"French Reference Center for Thrombotic Microangiopathies. Management of thrombotic thrombocytopenic purpura","volume":"24","author":"Coppo","year":"2017","journal-title":"Transfus Clin Biol"},{"issue":"91","key":"10.1016\/j.transci.2019.04.009_bib0145","article-title":"The role of plasma transfusion in massive bleeding: protecting the endothelial glycocalyx?","volume":"5","author":"Barelli","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.transci.2019.04.009_bib0150","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.tracli.2015.12.003","article-title":"Plasma therapy against infectious pathogens, as of yesterday, today and tomorrow","volume":"23","author":"Garraud","year":"2016","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.transci.2019.04.009_bib0155","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/nature22067","article-title":"Human umbilical cord plasma proteins revitalize hippocampal function in aged mice","volume":"544","author":"Castellano","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.transci.2019.04.009_bib0160","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1111\/trf.13100","article-title":"Comparative effectiveness of plasma prepared with amotosalen-UVA pathogen inactivation and conventional plasma for support of liver transplantation","volume":"55","author":"Cinqualbre","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2019.04.009_bib0165","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.transci.2018.02.005","article-title":"Solvent-detergent plasma for the treatment of thrombotic microangiopathies: a Canadian tertiary care centre experience","volume":"57","author":"Lee","year":"2018","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.transci.2019.04.009_bib0170","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/jth.13571","article-title":"International Working Group for Thrombotic Thrombocytopenic Purpura. Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies","volume":"15","author":"Scully","year":"2017","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.transci.2019.04.009_bib0175","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1111\/trf.13229","article-title":"Type of plasma preparation used for plasma exchange and clinical outcome of adult patients with acquired idiopathic thrombotic thrombocytopenic purpura: a French retrospective multicenter cohort study","volume":"55","author":"Toussaint-Hacquard","year":"2015","journal-title":"Transfusion"},{"issue":"May 21","key":"10.1016\/j.transci.2019.04.009_bib0180","article-title":"Characterization of efficacy and safety of pathogen inactivated and quarantine plasma in routine use for treatment of acquired immune thrombotic thrombocytopenic purpura","author":"Herbrecht","year":"2018","journal-title":"Vox Sang"},{"key":"10.1016\/j.transci.2019.04.009_bib0185","series-title":"du M\u00e9dicament et des Produits de Sant\u00e9. [Annual Hemovigilance Report, 2016]","author":"Fran\u00e7aise","year":"2017"},{"key":"10.1016\/j.transci.2019.04.009_bib0190","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.tmrv.2013.08.001","article-title":"Plasma treated with methylene blue and light: clinical efficacy and safety profile","volume":"27","author":"Lozano","year":"2013","journal-title":"Transfus Med Rev"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050219300588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050219300588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:50:09Z","timestamp":1761468609000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050219300588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S1473050219300588"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2019.04.009","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Types of fresh plasma with focus on therapeutic plasma exchange","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2019.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}